ARTICLE | Company News
EC approves Octapharma's Nuwiq
August 7, 2014 1:22 AM UTC
The European Commission approved Nuwiq simoctogog alfa from Octapharma AG (Lachen, Switzerland) to treat and prevent bleeding in patients with hemophilia A. The recombinant FVIII ( rFVIII) concentrate...